Abstract

PurposeSystemic lupus erythematosus (SLE) is an IgG-mediated autoimmune disease. Nipocalimab, which is in clinical development for the treatment of SLE, targets the IgG binding site on neonatal Fc receptor (FcRn)...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
A PHASE 1 PLACEBO-CONTROLLED SINGLE-DOSE STUDY OF NIPOCALIMAB ADMINISTERED AT DIFFERENT RATES OF INTRAVENOUS INFUSION IN HEALTHY ADULTS
Le Ling ... Jh Leu
Hematology, Transfusion and Cell Therapy | VOL. 44
Le Ling, et. al.Le Ling ... Jh Leu
01 Oct 2022
Pharmacokinetics and Pharmacodynamics of Nipocalimab Administered at Different Rates of Intravenous Infusion in Healthy Participants: Results of a Phase 1 Placebo-Controlled Single-Dose Study
Leona E Ling ... Jocelyn H Leu
Blood | VOL. 140
Leona E Ling, et. al.Leona E Ling ... Jocelyn H Leu
15 Nov 2022
P1535: SAFETY AND TOLERABILITY OF SINGLE ESCALATING DOSES OF INTRAVENOUS NIPOCALIMAB IN HEALTHY JAPANESE ADULTS: A RANDOMIZED, PHASE 1 PLACEBO-CONTROLLED STUDY
J Leu ... L Ling
HemaSphere | VOL. 6
J Leu, et. al.J Leu ... L Ling
23 Jun 2022
Tolerability and safety of facilitated subcutaneous immunoglobulin 20% in healthy adults: a phase 1 open-label study
Kimberly Duff ... Leman Yel
Clinical Immunology | VOL. 250
Kimberly Duff, et. al.Kimberly Duff ... Leman Yel
01 May 2023
View more papers

More From: Lupus Science & Medicine

Paper Title
Journal
Date
Author
iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus
Kamala Vanarsa ... Chandra Mohan
Lupus Science & Medicine | VOL. 11
Kamala Vanarsa, et. al.Kamala Vanarsa ... Chandra Mohan
23 May 2024
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations
Anca D Askanase ... Murray B Urowitz
Lupus Science & Medicine | VOL. 11
Anca D Askanase, et. al.Anca D Askanase ... Murray B Urowitz
22 May 2024
Development and validation of a risk scoring system to identify patients with lupus nephritis in electronic health record data
Zara Izadi ... Jinoos Yazdany
Lupus Science & Medicine | VOL. 11
Zara Izadi, et. al.Zara Izadi ... Jinoos Yazdany
20 May 2024
Positive psychosocial factors may protect against perceived stress in people with systemic lupus erythematosus with and without trauma history
Kimberly Dequattro ... Patricia P Katz
Lupus Science & Medicine | VOL. 11
Kimberly Dequattro, et. al.Kimberly Dequattro ... Patricia P Katz
15 May 2024
View more papers